Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -2,173 | -4,780 | -4,766 | -2,687 |
| Depreciation Amortization | 2,673 | 136 | 54 | 30 |
| Accounts receivable | -185 | N/A | -248 | -132 |
| Accounts payable and accrued liabilities | 469 | N/A | 360 | -119 |
| Other Working Capital | 427 | 1,270 | 337 | -24 |
| Other Operating Activity | -1,832 | 1,076 | 2,180 | 1,760 |
| Operating Cash Flow | $-623 | $-2,298 | $-2,084 | $-1,172 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -8 | -1 | -11 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -50 |
| Other Investing Activity | 0 | -60 | 0 | -50 |
| Investing Cash Flow | $-8 | $-61 | $-11 | $-50 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 3,197 | N/A | 1,992 | 1,088 |
| Debt Repayment | -2,695 | N/A | -122 | -87 |
| Other Financing Activity | -79 | 2,292 | -88 | -27 |
| Financing Cash Flow | $422 | $2,292 | $1,782 | $975 |
| Beginning Cash Position | 254 | 321 | 321 | 321 |
| End Cash Position | 46 | 254 | 8 | 74 |
| Net Cash Flow | $-208 | $-67 | $-313 | $-247 |
| Free Cash Flow | ||||
| Operating Cash Flow | -623 | -2,298 | -2,084 | -1,172 |
| Capital Expenditure | -8 | N/A | -11 | N/A |
| Free Cash Flow | -631 | -2,298 | -2,095 | -1,172 |